Search

Your search keyword '"Maimone, D"' showing total 300 results

Search Constraints

Start Over You searched for: Author "Maimone, D" Remove constraint Author: "Maimone, D"
300 results on '"Maimone, D"'

Search Results

1. Possible quantum fluctuations in the vicinity of the quantum critical point of $\mathbf{(Sr, Ca)_3Ir_4Sn_{13}}$ revealed by high-energy X-ray diffraction study

2. Evolution of Magnetic Order from the Localized to the Itinerant Limit

3. Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

4. Coupling of phonons with orbital dynamics and magnetism in CuSb$_2$O$_6$

5. Lattice dynamics of ASb2O6 (A=Cu,Co) with trirutile structure

6. Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

7. Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry

8. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

9. Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients with Primary Progressive Multiple Sclerosis

10. Comparative effectiveness in multiple sclerosis: A methodological comparison

11. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

12. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

13. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

14. Signs and symptoms of COVID-19 in patients with multiple sclerosis

15. Early non-disabling relapses are associated with a higher risk of disability accumulation in people with relapsing-remitting multiple sclerosis

16. The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

17. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

18. Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration

19. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study.

20. Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

21. Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS

22. Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

23. Signs and symptoms of COVID-19 in patients with multiple sclerosis

24. Impact of methodological choices in comparative effectiveness studies:application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

25. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

26. Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression (vol 208, 106180, 2021)

28. The Italian multiple sclerosis register

30. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.

31. Variability of the Response to Immunotherapy among Sub-groups of Patients with Multiple Sclerosis.

32. Association of latitude and exposure to ultraviolet B radiation with severity of multiple sclerosis.

33. Disability accrual in primary-progressive & secondaryprogressive multiple sclerosis.

34. Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression

35. Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis

36. Pregnancy in a modern day multiple sclerosis cohort: predictors of postpartum relapse and disability progression

37. Pregnancy in a modern day multiple sclerosis cohort: predictors of relapse during pregnancy

39. Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

40. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain: Abstracts of Symposia and free communications

41. Possible quantum fluctuations in the vicinity of the quantum critical point of $( Sr , Ca )_{3}Ir_{4}Sn_{13}$ revealed by high-energy x-ray diffraction

42. Introducing machine learning for full MS patient trajectories improves predictions for disability score progression.

43. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

47. Introducing Machine Learning for full MS patient trajectories improves predictions for disability score progression

48. Effectiveness of Natalizumab on Multiple Sclerosis patients: the Italian registry experience

49. 16-2 - Incidence de la sclérose en plaques dans la ville de Catane : une étude observationnelle sur 45 ans.

50. Evolution of Magnetic Order from the Localized to the Itinerant Limit

Catalog

Books, media, physical & digital resources